Printer Friendly

Browse Hepatitis B topic

Drug therapy subtopic

Articles

1-183 out of 183 article(s)
Title Author Type Date Words
FG Laments Funding For Hepatitis Treatment As 16 Million Nigerians Infected. Jul 28, 2021 724
First Patient Dosed in Phase 1 Study of VNRX-9945 for the Treatment of Chronic Hepatitis B Virus Infection. Jun 30, 2021 348
Grifols begins commercialising HyperHEP B. Jun 2, 2021 196
Grifols begins commercialising HyperHEP B. Jun 2, 2021 195
Enanta Pharmaceuticals Touts Positive Data from Part 2 of its Phase 1b Study of EDP-514 in Chronic Hepatitis B Virus Patients on Treatment with a Nucleoside Reverse Transcriptase Inhibitor. May 6, 2021 789
SciClone Pharma commences clinical trails to test hepatitis drug Zadaxin as COVID-19 vaccine immunity enhancer. Apr 26, 2021 190
SciClone Pharma commences clinical trails to test hepatitis drug Zadaxin as COVID-19 vaccine immunity enhancer. Apr 26, 2021 189
Brii, Vir Biotechnology VBI , start phase 2 trial of hepatitis B treatment. Apr 21, 2021 170
Comparison of the Efficacy of Entecavir and Tenofovir in Reducing Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients: A Real-Life Study in Turkey. Guzelbulut, Fatih; Gokcen, Pinar; Can, Guray; Adali, Gupse; Salturk, Ayca Gokcen Degirmenci; Aslan, Report Apr 1, 2021 6241
Intravenous drug abusers presenting with pseudoaneurysm and other surgical complications in Pakistan. Qudeer, Muhammad Amar; Naqi, Syed Asghar; Sarwar, , Muhammad Zeeshan; Mujahid, Hafiza Amina Report Feb 28, 2021 1676
US FDA Accepts VBI Vaccines BLA Filing for 3-Antigen Prophylactic Hepatitis B Vaccine. Feb 2, 2021 503
Vaccine Publishes Results from a Phase 4 Study of VBI Vaccines' Prophylactic 3-Antigen Hepatitis B Vaccine in Vaccine. Jan 15, 2021 553
EFFICACY OF FIRST AVAILABLE DIRECT-ACTING ANTIVIRAL AGENT IN TREATMENT OF CHRONIC HEPATITIS C; RESULTS FROM A SINGLE CENTRE IN PAKISTAN. Arif Qayyum Khan, Hala Mansoor, Javed Iqbal, Raja Yasser Shahbaz, Samina Fida and Muhammad Siddique Dec 31, 2020 4215
European Medicines Agency Acceptance of Marketing Authorization Application for 3-Antigen Prophylactic Hepatitis B Vaccine. Dec 23, 2020 438
Entecavir and Tenofovir Treatment in Patients With Hepatitis B Virus-Related Cirrhosis: A Comparison of Results of Two-Year Treatment/Hepatit B Virusuyla Iliskili Sirozu Olan Hastalarda Entekavir ve Tenofovir Tedavisi: Iki Yillik Tedavi Sonuclarinin Karsilastirilmasi. Alkan, Erhan; Akin, Mete; Tuna, Yasar Dec 1, 2020 3629
VBI Vaccines Submits Marketing Authorization Application for 3-Antigen Prophylactic Hepatitis B Vaccine to the European Medicines Agency. Nov 24, 2020 403
GlaxoSmithKline Reports Positive Data From Hepatitis B Drug Trial. Aug 28, 2020 346
Dicerna Touts Positive Clinical Data for Investigational Treatments RG6346 for Chronic Hepatitis B Virus and Nedosiran for Primary Hyperoxaluria. Aug 11, 2020 309
BioSig Technologies subsidiary ViralClear adds veteran drug developer to its scientific advisory board. Aug 6, 2020 416
Low-Content Quantitation in Entecavir Tablets Using 1064 nm Raman Spectroscopy. Kang, Yanlei; Zhou, Yushan; Wu, Qiaoyu; Wang, Ning; Zhou, Jianguang Jul 31, 2020 7115
Treatment of Hepatitis C with tablets more successful: LGH. Disease/Disorder overview Jul 27, 2020 429
Dynavax announces first patients dosed in Phase 1 trial of Medicago's vaccine. Jul 14, 2020 277
Enanta announces clinical trial progress for ED-514. Jul 9, 2020 213
Dynavax, Medicago announce collaboration to develop COVID-19 vaccine candidate. Jul 8, 2020 196
Drug Treatment of Patients with Liver Cirrhosis in a Tertiary Hospital in Northern Ghana: Does It Comply with Recommended Guidelines? Mohammed, Baba Sulemana; Aidoo, Matthew Clinical report Jun 30, 2020 5324
Enanta initiates program to discover antiviral drug candidates for COVID-19. Mar 13, 2020 231
Medicines, vaccine of Hepatitis available at 61 centres of Sindh: claims Dr. Zulfikar Dharejo. Nov 27, 2019 241
64,000 hepatitis patients provided free treatment. Nov 4, 2019 231
Hepatitis B viremia in HIV-coinfected individuals under antiretroviral therapy. Weissmann, Leonardo; de Melo Picone, Camila; Gomes Gouvea, Michele Soares; Abrao Ferreira, Paulo Rob Nov 1, 2019 6492
Gilead reports FDA approves Descovy for HIV pre-exposure prophylaxis. Oct 3, 2019 118
Cipla recalls 20,000 Hepatitis B drugs. Sep 25, 2019 585
Hepatitis B Treatment Market Expected to Register An Approx. CAGR Of 5.3% By 2023 With Global Industry Size, Share, Trends, Growth, Regional Analysis By Top 10 Key Players. Sep 9, 2019 868
Larkana short of Hepatitis medicines. Sep 2, 2019 697
Larkana short of Hepatitis medicines. Sep 1, 2019 713
HBsAg, Anti-HCV and Anti-HIV Seroprevalance Among Drug Users: a Retrospective Assessment. Altuglu, Imre; Tanyeri, Selin; Zeytinoglu, Aysin; Altintoprak, Ayse Ender Clinical report Sep 1, 2019 3991
Hepatitis B Treatment Market 2019 Size, Share, Trends, Growth, Competitor Landscape, Regional Study, Top Key Players Analysis and Industry Growth By 2024. Aug 29, 2019 856
No Hepatitis drugs in Larkana since past three months. Aug 28, 2019 704
People's life at stake as no Hepatitis drugs available in Larkana. Aug 28, 2019 704
No Hepatitis drugs available in Larkana. Aug 28, 2019 704
No Hepatitis drugs in Larkana since past three months. Aug 27, 2019 709
No Hepatitis drugs available in Larkana. Aug 27, 2019 709
Statins linked to cut in risk of cancer; MEDICINE. Aug 20, 2019 126
'Statins linked to cancer risk cut' MEDICINE. Aug 20, 2019 126
Enanta Pharmaceuticals Initiates Phase 1 Clinical Study of EDP-514, its Lead Core Inhibitor for the Treatment of Hepatitis B Virus. Jul 10, 2019 484
K-P procures hepatitis medicine worth Rs5m. Jun 5, 2019 519
Don't rush Hepatitis B treatment, Dr Atwine tells doctors. Jun 4, 2019 436
Response to: Comment on "48-Week Outcome after Cessation of Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Patient and the Associated Factors with Relapse". Xu, Wen-xiong; Peng, Liang Letter to the editor May 31, 2019 691
Center for treatment of HIV/AIDS to be opened at PMU Hospital. May 4, 2019 438
Prevalence of human immunodeficiency virus and Hepatitis (B and C) among drug users in a tertiary care public hospital. Apr 30, 2019 3147
Real-Life State of Anti-Hepatitis B Virus Drug Choice in Child-Bearing Age Male Patients and Effect on Fertility and Fetal Safety. Hu, Zhao X.; Ye, Yi.N.; Wu, Wei G.; Liang, Xu.J.; Wu, Qi.W.; Zhang, Ao; Zheng, Xing R.; Gao, Zhi L.; Medical condition overview Apr 30, 2019 3840
Gilead announces Japan's MHLW approves Biktarvy for HIV-1 treatment. Mar 26, 2019 212
Lamivudine's efficacy and safety in preventing mother-to-child transmission of hepatitis B: A meta-analysis. Khalighinejad, Pooyan; Alavian, Seyed Moayed; Fesharaki, Mohammad Gholami; Jalilianhasanpour, Rozita Report Jan 1, 2019 5177
Efficacy and Safety of the Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir Regimen for Chronic Hepatitis C in Hemodialysis Patients/Hemodiyaliz/Hastalarindaki Hepatit C Tedavisinde Paritaprevir/Ritonavir/Ombitasvir ve Dasabuvir Rejiminin Etkinlik ve Guvenligi. Tosun, Guven Gurkan; Sultanova, Fidan; Nihan, A.K.; Hizel, Kenan Jan 1, 2019 4157
Gilead receives China NMPA approval for Descovy for the treatment of HIV-1. Dec 4, 2018 396
Convenient chronic hepatitis B candidates for antiviral cessation and retreatment after relapse: When and who? Demirtas, Coskun Ozer; Ozdogan, Osman Cavit Report Nov 1, 2018 1421
MYR Pharma receives US FDA breakthrough therapy designation for Myrcludex to treat chronic Hepatitis B and D infections. Oct 24, 2018 174
MYR Pharma receives US FDA breakthrough therapy designation for Myrcludex to treat chronic Hepatitis B and D infections. Oct 24, 2018 178
Assessment of histopathological alterations in patients with chronic hepatitis B infection following long-term oral antiviral therapy. Sahin, Ahmet; Namiduru, Mustafa; Balkan, Ayhan; Karaoglan, Ilkay; Gulsen, Murat T. Oct 1, 2018 4411
Survey: NACA provides treatment to HIV victims. Sep 27, 2018 640
Current and future directions for the management of hepatitis B. Dusheiko, G. Report Aug 15, 2018 8831
Assembly Biosciences receives fast track designation for ABI-H0731 for HepB. Jul 25, 2018 303
Efficacy of Pegylated Interferon Monotherapy versus Sequential Therapy of Entecavir and Pegylated Interferon in Hepatitis B e Antigen-Positive Hepatitis B Patients: A Randomized, Multicenter, Phase IIIb Open-Label Study (POTENT Study). Jun, Dae; Ahn, Sang; Kim, Tae; Sohn, Joo; Kim, Sang; Lee, Se; Kim, Byung; Kim, Dong; Kim, Ja; Kim, H Report Jul 20, 2018 3148
ContraVir announces FDA approval of IND, initiates clinical program of CRV431. Jun 14, 2018 200
Breckenridge Pharmaceutical wins final US FDA approval for Entecavir tablets (Baraclude) ANDA for hepatitis B infection. Mar 28, 2018 200
Breckenridge Pharmaceutical wins final US FDA approval for Entecavir tablets (Baraclude) ANDA for hepatitis B infection. Mar 28, 2018 196
No medicines available at Hepatitis Centres in Sindh. Feb 11, 2018 275
Gilead announces FDA approval of Biktarvy combo treatment for HIV-1 infection. Feb 7, 2018 120
GC Pharma to Proceed with Phase 2/3 Clinical Trial of Recombinant Treatment for Prevention of Hepatitis B Infection After Liver Transplant. Jan 23, 2018 171
GC Pharma to proceed with Phase 2/3 clinical trial for hepatitis B drug GC1102. Jan 18, 2018 172
GC Pharma to proceed with Phase 2/3 clinical trial for hepatitis B drug GC1102. Jan 18, 2018 168
Role of nucleoside/nucleotide analogues and low-dose hepatitis B immune globulin in prophylaxis of hepatitis B recurrence among cadaveric liver transplant recipients. Ajayi, Tokunbo; Luu, Harry; Saberi, Behnam; Hamilton, James P.; Konduk, Bugra Tolga; Ozseker, Burak; Jan 1, 2018 3759
Mathematical Modeling of the Adaptive Immune Responses in the Early Stage of the HBV Infection. Allali, Karam; Meskaf, Adil; Tridane, Abdessamad Report Jan 1, 2018 7605
48-Week Outcome after Cessation of Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Patient and the Associated Factors with Relapse. Xu, Wen-xiong; Zhang, Qian; Zhu, Xiang; Chao-shuangLin; Chen, You-ming; Deng, Hong; Mei, Yong-yu; Zh Report Jan 1, 2018 5871
Free medicines for hepatitis B and C patients. Dec 25, 2017 138
Hepatitis prevention, treatment clinic inaugurated. Dec 12, 2017 283
Quantitative HBsAg monitoring in hepatitis B virus treatment. Gish, Robert Dec 1, 2017 1138
Meeting on drug use, spreading of HIV/AIDS held. Nov 24, 2017 320
Negative Correlation of Serum Hepatitis B Surface Antigen and Hepatitis B e Antigen Levels with the Severity of Liver Inflammation in Treatment-naive Patients with Chronic Hepatitis B Virus Infection. Zhang, Lu; Li, Ming-Hui; Cao, Wei-Hua; Qi, Tian-Lin; Lu, Yao; Wu, Shu-Ling; Hao, Hong-Xiao; Shen, Ge Report Nov 20, 2017 4164
Antiviral Medications, Part 3: Evidence-Based Treatment of Hepatitis B. Branstetter-Hall, Jo Ellen; Felicilda-Reynaldo, Rhea Faye D. Disease/Disorder overview Nov 1, 2017 4005
Efficacy of Real-world Entecavir Therapy in Treatment-naive Chronic Hepatitis B Patients. Xie, Yan-Di; Ma, Hui; Feng, Bo; Wei, Lai Report Sep 20, 2017 5134
Eiger wins US FDA's fast track designation for pegylated interferon lambda for the treatment of hepatitis delta virus infection. Jul 28, 2017 200
Efficacy and Safety of Tenofovir Disoproxil Treatment for Chronic Hepatitis B Patients with Genotypic Resistance to Other Nucleoside Analogues: A Prospective Study. Zhou, Jing; Liu, Yue-Ying; Lian, Jiang-Shan; Pan, Li-Fang; Yang, Jian-Le; Huang, Jian-Rong Report Jul 27, 2017 4615
Zydus Cadila granted final approval by FDA to market Entecavir. Jun 27, 2017 176
Zydus Cadila granted final approval by FDA to market Entecavir. Jun 27, 2017 172
Phenotypic and genotypic shifts in hepatitis B virus in treatment-naive patients, Taiwan, 2008-2012. Yeh, Chau-Ting; Liang, Kung-Hao; Chang, Ming-Ling; Hsu, Chao-Wei; Chen, Yi-Cheng; Lin, Chih-Lang; Li May 1, 2017 1799
Predictors of HBeAg seroconversion after long-term nucleos(t)ide analogues treatment for chronic hepatitis B: a multicenter study in real clinical setting. Yu, Weiyan; Wang, Yadong; Shen, Chuan; Ji, Ru; Zhang, Li; Zhao, Xin; Su, Miao; Zhang, Ying; He, Weny May 1, 2017 4634
Bartell Drugs rolls out specialty Rx services. Apr 3, 2017 408
Indian government implements measures that will boost patients' access to HIV and Hepatitis B & C treatments. Mar 23, 2017 248
Indian government implements measures that will boost patients' access to HIV and Hepatitis B & C treatments. Mar 23, 2017 244
Influence of Treg cells and HBV genotype on sustained response and drug resistance in the treatment with nucleoside drugs. Zhang, Y.R.; Li, B.; Wang, C.X.; Zhou, N.; Qi, W.; Li, X.L.; Wu, L.Y.; Wei, S.F.; Zhang, Y.D. Report Mar 1, 2017 4506
The Effect of Hepatosteatosis on Response to Antiviral Treatment in Patients with Chronic Hepatitis B: A Meta-Analysis. Zhu, Yongfen; Yang, Qiao; Lv, Fangfang; Yu, Yunsong Report Jan 1, 2017 5627
Factors Related to Significant Improvement of Estimated Glomerular Filtration Rates in Chronic Hepatitis B Patients Receiving Telbivudine Therapy. Lin, Te-Fu; Hsu, Ping-I.; Lin, Kung-Hung; Tsay, Feng-Woei; Tsai, Tzung-Jiun; Chen, Yan-Hua; Yu, Hsie Report Jan 1, 2017 5939
Add-on Pegylated Interferon Alpha-2a Therapy in Chronic Hepatitis B Japanese Patients Treated with Entecavir. Tamai, Hideyuki; Ida, Yoshiyuki; Shingaki, Naoki; Shimizu, Ryo; Fukatsu, Kazuhiro; Itonaga, Masahiro Report Jan 1, 2017 5337
Expression of Interferon Effector Gene SART1 Correlates with Interferon Treatment Response against Hepatitis B Infection. Li, Yong; Zhu, Chuanlong; Wang, Faxi; Zhu, Tiantian; Li, Jun; Liu, Shufeng; Xiao, Fei Report Jan 1, 2017 5435
Oncolytic Virus-Based Immunotherapies for Hepatocellular Carcinoma. Yoo, So Young; Badrinath, Narayanasamy; Woo, Hyun Young; Heo, Jeong Report Jan 1, 2017 8717
Early Onset of Tenofovir-Related Fanconi Syndrome in a Child with Acute Hepatitis B: A Case Report and Systematic Review of Literature. Pascale, Renato; Guardigni, Viola; Badia, Lorenzo; Volpato, Francesca; Viale, Pierluigi; Verucchi, G Clinical report Jan 1, 2017 2970
TDF Monotherapy Is Effective Regardless of Prior Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Patients in China. Huang, Mingxing; Lin, Guoli; Shi, Hong; Wu, Yuankai; Jie, Yusheng; Zhu, Zhe; Chong, Yutian Report Jan 1, 2017 4609
Reversal of Proximal Renal Tubular Dysfunction after Nucleotide Analogue Withdrawal in Chronic Hepatitis B. Sobhonslidsuk, Abhasnee; Numthavaj, Pawin; Wanichanuwat, Jirachaya; Sophonsritsuk, Areepan; Petraksa Report Jan 1, 2017 5433
Poxel announces Phase 1 Initiation of EYP001 by ENYO Pharma SA for the treatment of chronic hepatitis b virus infection. Dec 20, 2016 258
Poxel announces Phase 1 Initiation of EYP001 by ENYO Pharma SA for the treatment of chronic hepatitis b virus infection. Dec 20, 2016 254
Hepatitis B infection in HIV-1-infected patients receiving highly active antiretroviral therapy in Lome, Togo: prevalence and molecular consequences. Patassi, A.A.; Benaboud, S.; Landoh, D.E.; Salou, M.; Dagnra, A. Claver; Saka, B.; Krivine, A.; Meri Jun 1, 2016 5048
Vital signs: increased medicaid prescriptions for preexposure prophylaxis against HIV infection--New York, 2012-2015. Laufer, Franklin N.; O'Connell, Daniel A.; Feldman, Ira; Zucker, Howard A. Nov 27, 2015 3569
Use of Tenofovir or Entecavir recommended for the treatment of chronic hepatitis B. Apr 15, 2015 624
Efficacy of Entecavir therapy in elderly patients with chronic hepatitis B infection. Tan, You-wen; Ge, Guo-hong; Sun, Li; Zhou, Xing-bei; Peng, Pen-li; Chen, Li Report Nov 1, 2014 907
Acute hepatic failure caused by hepatitis B virus reactivation in patients receiving immunomodulatory agents for autoimmune diseases. Hsu, Sung-Yu; Ho, Cheng-Maw; Lee, Po-Huang; Lai, Hong-Shiee; Hu, Rey-Heng Sep 1, 2014 4033
High dose of lamivudine and resistance in patients with chronic hepatitis B. Wani, Hamid Ullah; Kaabi, Saad Al; Sharma, Manik; Singh, Rajvir; John, Anil; Derbala, Moutaz; Mohann Report Jan 1, 2014 3044
HBV reactivation in patients treated with antitumor necrosis factor-alpha (TNF-[alpha]) agents for rheumatic and dermatologic conditions: a systematic review and meta-analysis. Cantini, Fabrizio; Boccia, Stefania; Goletti, Delia; Iannone, Florenzo; Leoncini, Emanuele; Panic, N Report Jan 1, 2014 6754
Antiviral treatment among pregnant women with chronic hepatitis B. Fan, Lin; Owusu-Edusei, Kwame, Jr.; Schillie, Sarah F.; Murphy, Trudy V. Report Jan 1, 2014 4646
Wrong vaccine lands 114 children in India hospital. Sep 17, 2013 338
Wrong Vaccine Lands 114 Bengal Children in Hospital. Sep 16, 2013 327
i"?SciVac files for FDA approval of hepatitis B vaccine distribution in US. Jul 29, 2013 143
i"?SciVac files for FDA approval of hepatitis B vaccine distribution in US. Jul 29, 2013 139
Tenofovir alone suffices against lamivudine-resistant hep B. Osterweil, Neil Jan 1, 2013 655
The effect of entecavir on Hepatitis B virus-related cirrhosis. Lei Feng; Yong-Jun Chen; Yi Tang; Jian-Yu Xu; Jing-Yun Fan Report Dec 31, 2012 2166
Institute for Hepatitis and Virus Research Receives Significant State Grant for Two-Year Research Project Focusing on New Liver Cancer Treatment. Sep 16, 2012 522
A*STAR Scientists: Earlier Treatment for Young Patients With Chronic Hepatitis B May Be More Effective in Clearing Virus. Sep 6, 2012 926
Drug users recommended to take hepatitis B vaccine. Jul 23, 2012 223
Comparison of entecavir and adefovir for the treatment of chronic hepatitis B. Zhao, Si-Hai; Liu, En-Qi; Cheng, Da-Xin; Li, Ya-Feng; Wang, Yan-Li; Chen, Yu-Long; Sun, Wen-Tao; Yan Jul 1, 2012 4984
EFFICACY OF TELBIVUDINE IN THE TREATMENT OF HBeAg NEGATIVE CHRONIC HEPATITIS B WITH NORMAL BASELINE ALT LEVELS. Mehr, Muhammad Tariq; Khan, Humera; Iman, Noor Ul; Khan, Habibullah Report Jun 30, 2012 2278
YMDD motif mutations in chronic hepatitis B antiviral treatment naive patients: a multi-center study. Tan, You-Wen; Ge, Guo-Hong; Zhao, Wei; Gan, Jian-He; Zhao, Yun; Niu, Zhi-Lin; Zhang, Dong-Jun; Chen, Report May 1, 2012 3958
Why it's time to say goodbye to stavudine ... everywhere. Andrieux-Meyer, Isabelle; Clayden, Polly; Collins, Simon; Geffen, Nathan; Goemaere, Eric; Harrington Report Mar 1, 2012 2876
Entecavir as specific antiviral therapy in selected cases of severe acute hepatitis B. Streinu-Cercel, Oana; Streinu-Cercel, Anca; Preotescu, Liliana Lucia; Streinu-Cercel, Adrian Report Mar 1, 2012 2378
Clinical Proceedings of Baqai Medical University' Silver Jubilee Symposium. Jan 31, 2012 1952
Gilead unveils new 5-year trial data on Viread's efficacy in HBV patients. Clinical report Nov 7, 2011 435
Simultaneous detection of hepatitis B virus genotypes and mutations associated with resistance to lamivudine, adefovir, and telbivudine by the polymerase chain reaction-ligase detection reaction. Wang, Yong-Zhong; Xiao, Jun-Hua; Liu, Long-Gen; Ye, Chun-Yan; Shen, Hong-Yu; Xu, Tian-Min; Zhu, Ke-Z Nov 1, 2011 4190
Hepatitis C prevalence in injecting drug users highest in U.S. Brunk, Doug Aug 1, 2011 624
The prevalence of hepatitis B infection in a rural South African HIV clinic. Boyles, Tom H.; Cohen, Karen Report Jul 1, 2011 1664
Asian Activities Report for June 8, 2011: Agenix (ASX:AGX) On Track To Begin Clinical Trials In China For The New Hepatitis B Drug. Jun 8, 2011 306
Assay measures DNA viral load of hepatitis B. Brief article Feb 1, 2011 122
Chronic HBV patients should be considered for treatment if ALT is constantly raised-Prof. Wasim Jafri. Jan 31, 2011 1569
Entecavir approval for hepatitis B expanded. Mechcatie, Elizabeth Nov 15, 2010 299
Potential threat to hepatitis B control emerging: vaccine escape mutants are a result of universal immunization. Jancin, Bruce Sep 15, 2010 746
Efficacy of immunization against hepatitis B virus infection in acute leukemia / Akut losemide hepatit B virusu enfeksiyonuna karsi asilama etkililigi. Dolai, Tuphan Kanti; Mahapatra, Manoranjan; Pati, Hara Prasad; Mishra, Pravas; Seth, Tulika; Bhargav Sep 1, 2010 4374
The dawn of a new era: transforming our domestic response to hepatitis B & C: activity 1: overview of the viral hepatitis problem. Lok, Anna S. F.; Kim, W. Ray; El-Serag, Hashem B.; Maddrey, Willis C. Disease/Disorder overview Apr 1, 2010 3323
The dawn of a new era: transforming our domestic response to hepatitis B & C: activity 2: understanding the natural history of chronic HBV and HCV infections. Thomas, David L.; Bisceglie, Adrian M. Di; Alter, Harvey J.; Terrault, Norah A. Report Apr 1, 2010 2885
Ignorance or apathy? Editorial Mar 1, 2010 643
Eisai Launches REVOVIR(R) in the Philippines for the Treatment of Chronic Hepatitis B. Clinical report Feb 24, 2010 455
Eisai Announces Approval of Clevudine for the Treatment of Chronic Hepatitis B in the Philippines. Mar 13, 2009 474
Hepatitis B in HIV patients: what is the current treatment and what are the challenges? Soriano, Vincent; Tuma, Paula; Vispo, Eugenia; Labarga, Pablo; Fernandez, Jose Vicente; Medrano, Jos Report Mar 1, 2009 4761
Lamivudine for chronic hepatitis B: a brief review. Palumbo, Emilio Report Oct 1, 2008 1939
Cost-effectiveness of entecavir versus lamivudine for the suppression of viral replication in chronic hepatitis B patients in Brazil. Costa, Anna Maria N.; L.'Italien, Gilbert L.; Nita, Marcelo Eidi; Araujo, Evaldo Stanislau A. Report Oct 1, 2008 4184
Pharmacotherapy of hepatitis B infection: a brief review. Quan, David J. Clinical report Sep 1, 2008 2531
Acute pancreatitis associated with lamivudine therapy for chronic B hepatitis. Tuon, Felipe Francisco; Guastini, Cristina Maria de Fatima; Boulos, Maria Ivete Castro Clinical report Aug 1, 2008 753
Occult hepatitis B virus infection in immunocompromised patients. Jardim, Ruth Nogueira Cordeiro Moraes; Goncales, Neiva Sellan Lopes; Pereira, Josiane Silveira Felix Clinical report Aug 1, 2008 4364
Clinical implications of resistance patterns against HBV-polymerase inhibitors for the treatment of chronic hepatitis B. Mauss, Stefan Dec 1, 2007 2155
HBV drug may fuel HIV drug resistance. Aug 1, 2007 254
Telbivudine tops lamivudine for HBV at 2 years. Mahoney, Diana Feb 15, 2007 693
FDA approves new treatment for chronic hepatitis B in adults. Dec 1, 2006 330
Lamivudine is still useful against some hepatitis B. Boschert, Sherry Clinical report Oct 1, 2006 497
Study says vaccine R&D remains on slow track. Brief article Jul 24, 2006 192
Nabi gets positive opinion from FDA panel for injectable hepatitis B drug use after liver transplant. Jul 19, 2006 273
Entecavir vs. lamivudine for HBV. Dixon, Bruce K.; Evans, Jeff Brief article Apr 15, 2006 242
Multidrug approach is coming for hepatitis B. Jancin, Bruce Mar 15, 2006 611
Drug pipeline for hepatitis B treatment said to be prolific. Jancin, Bruce Mar 1, 2006 572
Idenix, Novartis seeking FDA, European approval to market new treatment for chronic hepatitis B. Brief Article Feb 13, 2006 208
Vaccine-Preventable Hepatitis (VPH) and high-risk patients with HIV. Advertisement Jun 1, 2005 1171
FDA approves entecavir for chronic hepatitis B. Mechcatie, Elizabeth Apr 15, 2005 863
Investigational agent promising for hepatitis B. Kerr, Martha Apr 1, 2005 402
Hepatitis B: mono vs. combo therapy. Evans, Jeff Brief Article Mar 15, 2005 149
Delaying hepatitis B progression. Evans, Jeff Brief Article Nov 1, 2004 197
Treating chronic hepatitis B. Evans, Jeff Brief Article Oct 15, 2004 188
Adefovir for hepatitis B triggered few drug-resistant viral mutants. Zoler, Mitchel L. Jul 15, 2004 573
Hepsera reduces lamivudine-resistant HBV levels in liver transplant patients. Feb 16, 2004 343
The hepatitis information you need to know. Disease/Disorder overview Jan 1, 2004 995
Treating chronic HBV, part 1. (Clinical Capsules). Evans, Jeff Brief Article May 15, 2003 164
Treating chronic HBV, part 2. (Clinical Capsules). Evans, Jeff Brief Article May 15, 2003 144
Tenofovir promising against hepatitis B infections in HIV. (Small Trial in Nonresponders). Sullivan, Michele G. Brief Article Mar 15, 2003 274
Hepsera. (New & Approved). Nov 15, 2002 331
Panel backs adefovir for chronic hepatitis B. (Benefit Seen in Lamivudine Resistance). Mechcatie, Elizabeth Sep 15, 2002 553
Lamivudine quells HBV. (Clinical Capsules). Brief Article Aug 15, 2002 159
Lamivudine vs. placebo for HBV. (Journal Scan). Splete, Heidi Brief Article Jul 1, 2002 140
Limit lamivudine therapy to patients with moderate to severe hepatitis B. (Future Antivirals may be more Effective). Kirn, Timothy F. May 1, 2002 516
Adefovir Dipivoxil in Chronic HBV. (Once-Daily Investigational Therapy). DeMott, Kathryn Brief Article Mar 1, 2002 757
Epivir HBV has limited promise in chronic HBV. (Resistant Mutation Common). Kubetin, Sally Koch Product/Service Evaluation Mar 1, 2002 428
Adefovir reduces fibrosis in precore mutant HBV. (Strain Does Not Produce E Antigen). Mechcatie, Elizabeth Feb 15, 2002 525
Data Still Lacking on Drug Tx of Chronic HBV. (Interferon or Lamivudine Therapy). Kubetin, Sally Koch Nov 1, 2001 582
Epivir-HBV Now Approved for Children, Teens. MECHCATIE, ELIZABETH Oct 1, 2001 428
Powderject DNA vaccine achieves protective immunity. Brief Article Apr 1, 2001 850
Update: Expanded Availability of Thimerosal Preservative-Free Hepatitis B Vaccine. Brief Article Jul 21, 2000 485
Lamivudine Treats HBV in Asians. ZOLER, MITCHEL L. Dec 1, 1999 351
New hope for hepatitis B patients. Oct 1, 1990 422
Chimp test for oral hepatitis B vaccine. Hart, S. Sep 23, 1989 406
One-two punch for hepatitis B. Eron, carol Aug 6, 1988 680

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |